Bryan Hubbard

In a riveting conversation, Bryan Hubbard, Executive Director of the American Ibogaine Initiative, sheds light on the transformative potential of Ibogaine therapy. He discusses how it disrupts addiction cycles and rewires trauma pathways, providing hope for conditions like depression and PTSD. Hubbard also highlights promising studies, especially among veterans, revealing significant improvements in cognitive function. Despite its unapproved status by the FDA, he advocates for a shift in public policy to embrace this innovative treatment, offering a new path for healing.

Bryan Hubbard, Executive Director of the American Ibogaine Initiative and former head of Kentucky's Opioid Abatement Advisory Commission, discusses groundbreaking therapies using ibogaine for opioid addiction and brain health. He reveals how ibogaine can reset neurochemistry and explores its potential in treating conditions like Parkinson's disease. The conversation delves into the spiritual and political aspects of psychedelic medicine, highlighting Texas as a new frontier for research and the urgent need for innovative treatment options in combating the opioid crisis.